Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 2

Status

Completed 8Unknown 6Recruiting 6Terminated 3Active not recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Genitourinary 6

Conditions

Breast Neoplasms 1296Carcinoma, Non-Small-Cell Lung 793Neoplasms 787Colorectal Neoplasms 760Stomach Neoplasms 587Carcinoma, Hepatocellular 581Prostatic Neoplasms 514Lung Neoplasms 466Pancreatic Neoplasms 421Rectal Neoplasms 336Recurrence 314Neoplasm Metastasis 308Leukemia, Myeloid, Acute 293Colonic Neoplasms 283Multiple Myeloma 280Lymphoma 276Esophageal Neoplasms 273Uterine Cervical Neoplasms 272Ovarian Neoplasms 263Melanoma 246Head and Neck Neoplasms 245Precursor Cell Lymphoblastic Leukemia-Lymphoma 210Brain Neoplasms 195Lymphoma, Large B-Cell, Diffuse 187Nasopharyngeal Carcinoma 182Leukemia 173Lymphoma, Non-Hodgkin 171Liver Neoplasms 165Glioblastoma 160Polycystic Ovary Syndrome 157

Interventions

pembrolizumab 1enzalutamide 1abiraterone 1Radium-223 1Carboplatin 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × Interventional × Castration-resistant Prostate Cancer × Clear all
NCT03305224 2021-09-09

CORE-OCU

Osaka City University

Phase 2 Unknown
10 enrolled
Genitourinary

Castration-resistant Prostate Cancer

NCT04839055 2021-04-09

CoA-CRPC

Jiangnan University

Phase 1/2 Unknown
50 enrolled
Genitourinary

Castration-resistant Prostate Cancer

NCT03506997 2020-07-22

PERSEUS1

Institute of Cancer Research, United Kingdom

Phase 2 Unknown
100 enrolled
Genitourinary

Castration-resistant Prostate Cancer

NCT04148885 2019-11-04

A Trial of Paclitaxel (Albumin-binding) for Castration-resistant Prostate Cancer

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 1/2 Unknown
44 enrolled
Genitourinary

Castration-resistant Prostate Cancer

NCT03696186 2018-10-09

STAMP

Tianjin Medical University Second Hospital

Phase 2 Unknown
300 enrolled
Genitourinary

Castration-resistant Prostate Cancer

NCT01487902 2011-12-08

The Role of Androgen Deprivation Treatment (ADT) in Docetaxe-Prednisolone Chemotherapy for Castrate-Resistant Prostatic Cancer

Asan Medical Center

Phase 2 Unknown
90 enrolled
Genitourinary

Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡